CMPX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases...

Stats
Dagens volum	65 665.00
Gjennomsnittsvolum	375 306
Markedsverdi	184.85M
EPS	$0 ( 2024-03-20 )
Neste inntjeningsdato	( $0 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.39
ATR14	$0.0120 (0.83%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-08	Boylan James P	Buy	40 000	Stock Option (Right to Buy)
2024-02-09	Gray Mary Ann	Buy	40 000	Stock Option (Right to Buy)
2024-02-09	Lindahl Richard S	Buy	40 000	Stock Option (Right to Buy)
2024-02-09	Gordon Carl L	Buy	40 000	Stock Option (Right to Buy)
2024-02-09	Chiniara Ellen	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
93.94
Last 94 transactions
Buy: 28 287 388 \| Sell: 226 920

Volum Korrelasjon

Lang: 0.04 (neutral)

Kort: 0.05 (neutral)

Signal:(49.093) Neutral

Compass Therapeutics, Korrelasjon

10 Mest positive korrelasjoner
PIXY	0.935
WTBA	0.915
UPC	0.91
LLNW	0.909
GSMG	0.908
ALXO	0.905
ENNV	0.902
YJ	0.902
BMRA	0.897
LVTX	0.893

10 Mest negative korrelasjoner
HHGC	-0.937
KYCH	-0.936
UONE	-0.936
OLED	-0.931
PPD	-0.93
SIBN	-0.927
CDNS	-0.927
NVTS	-0.923
ALYA	-0.923
MELI	-0.923

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Compass Therapeutics, Korrelasjon - Valuta/Råvare

-0.20
( neutral )

0.21
( neutral )

0.00
( neutral )

0.09
( neutral )

-0.27
( neutral )

0.22
( neutral )

Compass Therapeutics, Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$-1.90M (0.00 %)
EPS:	$-0.350

FY	2022
Omsetning:	$0
Bruttogevinst:	$-1.90M (0.00 %)
EPS:	$-0.350

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.583

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.566

Financial Reports:

No articles found.

Compass Therapeutics,

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137. Its product candidates also comprise CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Sanntidsoppdatering for Compass Therapeutics, [CMPX]

Upcoming Earnings Alert